Trelegy Ellipta
fluticasone/umeclidinium/vilanterol, 100/62.5/25 mcg INH BID
- Step therapy
- 3 of 3 met
- Est. cost
- $0 to $35 / mo
- PA required
- No
Coverage research for clinicians
Manoa reads the policy documents, compares the options, works out the step therapy logic, and returns a ranked answer with citations. You make the prescribing call.
Solo $79/mo. 7-day free trial. No EHR integration required.
Trelegy Ellipta
fluticasone/umeclidinium/vilanterol, 100/62.5/25 mcg INH BID
2 ranked alternatives also prepared
The problem
You've seen the patient. You have a treatment in mind. The EHR shows some information about coverage, but you don't trust it. So you open a browser tab, find the payer's policy document, maybe read it, maybe call the payer. Eventually you pick something, write the prescription, and hope. That work doesn't have a name in the EHR. It doesn't have a name in the survey data either, which lumps it under "prior authorization" even though most of it happens before any PA paperwork exists. It's the work that makes the paperwork possible, and almost no software touches it.
13 hrs/wk
per clinician on insurance work
63%
of clinicians can't tell in advance whether a Rx needs PA
27%
say EHR coverage data is rarely or never accurate
AMA 2025 Prior Authorization Physician Survey (n=1,000, collected December 2025).
How it works
Describe
Type the case the way you'd describe it to a colleague. Condition, plan, anything else you know. Partial inputs are fine; Manoa asks follow-up questions to fill in what matters.
Compare
Manoa returns a ranked comparison across coverage, cost, step therapy, and speed. Drill into any option to see why it's covered, what's required, and the cash-pay path.
Decide
Pick the right path with full visibility into what's actually accessible for this patient. No more best guesses. No more pajama-time research.
The product
Manoa runs in a browser tab next to your EHR. Describe a patient the way you'd describe them to a colleague. Manoa returns a side-by-side comparison of treatment options for this specific patient and this specific plan, with coverage likelihood, step therapy requirements, estimated cost, speed to approval, and a cash-pay alternative for every option. Whether you know what to prescribe, you're working it out, or insurance has shut the door, same product, same flow.
Tier 1 · Strong
Dupixent
dupilumab · 300 mg SC q2w
Tier 2 · Worth considering
Nucala
mepolizumab · 100 mg SC q4w
Tier 3 · Long shot
Ohtuvayre
ensifentrine · 3 mg INH BID
Illustrative example. 62-year-old patient with severe eosinophilic COPD on Aetna Commercial PPO (CA). Real coverage depends on the live plan policy.
From our design partners
“They won't cover that? Well what will they cover? This is where you waste the most amount of time. I don't have x-ray vision to know what can be covered instead.”
“It's like navigating an information jungle to answer what is covered for this patient, this product, this insurance, this condition, and this time.”
“This is exactly what we need.”
Pro tier, coming Q3
The scribe drafts the note. Manoa coverage-checks every prescription in the background. By the time you review the note, the coverage analysis is already there, with primary and alternative options ranked for the patient's plan.
Works on top of your existing scribe (Freed first, others added as our users adopt them). No new workflow to learn.
Scribed note
HPI: 62yo with severe eosinophilic COPD, persistent dyspnea on albuterol + ICS-LABA, eos 380.
A&P: Severe COPD with eosinophilic phenotype. Add-on biologic.
Plan: Trelegy Ellipta 100/62.5/25 mcg INH BID.
Manoa coverage analysis
Trelegy Ellipta
fluticasone/umeclidinium/vilanterol, 100/62.5/25 mcg INH BID
Likely covered2 ranked alternatives also prepared (Dupixent, Nucala).
and we'll prioritize you for V1.5 access.
Pricing
Solo
Pro
Coming Q3Practice
Coming Q4On the AMA 13-hour anchor, Pro is roughly 4% of total PA burden. About 24x ROI in year one. Heavier-PA specialties (rheumatology, GI, derm, oncology, psychiatry) scale higher.
Manoa rolls out by hand to clinicians at small and mid-sized practices. Add your email and we'll send you a sign-up link as soon as we have a seat for you.
We don't sell or share your information. Manoa is designed for queries without PHI: no patient names, MRNs, or other identifiers. Unsubscribe at any time.